{{Short description|Synthetic estrogen}} {{Drugbox | Verifiedfields = | Watchedfields = | verifiedrevid = | IUPAC_name = 4-[(2''R'',3''S'')-5,5,5-trifluoro-3-(4-hydroxyphenyl)pentan-2-yl]phenol | image = Terfluranol.svg | image_class = skin-invert-image | width =
<!--Clinical data--> | tradename = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_category = | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =
<!--Pharmacokinetic data--> | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =
<!-- Identifiers --> | CAS_number_Ref = {{cascite|correct|CAS}} | CAS_number = 64396-09-4 | CAS_supplemental = | ATC_prefix = None | ATC_suffix = | ATC_supplemental = | PubChem = 3085293 | IUPHAR_ligand = | DrugBank_Ref = | DrugBank = | ChemSpiderID_Ref = | ChemSpiderID = 2342233 | UNII = WUF1DL156G | KEGG = | ChEBI = | ChEMBL = 2105462
<!--Chemical data--> | C=17 | H=17 | F=3 | O=2 | molecular_weight = | smiles = CC(C1=CC=C(C=C1)O)C(CC(F)(F)F)C2=CC=C(C=C2)O | StdInChI_Ref = | StdInChI = 1S/C17H17F3O2/c1-11(12-2-6-14(21)7-3-12)16(10-17(18,19)20)13-4-8-15(22)9-5-13/h2-9,11,16,21-22H,10H2,1H3/t11-,16-/m0/s1 | StdInChIKey_Ref = | StdInChIKey = KTUJPJJUMKZGCV-ZBEGNZNMSA-N | synonyms = }}
'''Terfluranol''' (INN, BAN; development code '''BX-428''') is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that was developed for the treatment of breast cancer but was never marketed.<ref name="Elks2014">{{cite book| vauthors = Elks J |title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PP1|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|page=1161}}</ref><ref name="Polonii1984">{{cite book|author=Polska Akademia Nauk. Komitet Badania Polonii|title=II Kongres Uczonych Polskiego Pochodzenia: zbiór materiałów|url=https://books.google.com/books?id=_-VjAAAAIAAJ|year=1984|publisher=Zakład Narodowy im. Ossolińskich|isbn=978-83-04-01670-5|page=451}}</ref> It was described in the medical literature in 1974.<ref name="Elks2014" />
==See also== * Acefluranol * Bifluranol * Pentafluranol
==References== {{Reflist|2}}
{{Estrogen receptor modulators}}
Category:Organofluorides Category:4-Hydroxyphenyl compounds Category:Synthetic estrogens Category:Trifluoromethyl compounds
{{genito-urinary-drug-stub}}